Want to see PLXS full AI Analyst Report?
PLXS Stock Chart & Stats
$228.64
$0.86(0.54%)
At close: 4:00 PM EST
$228.64
$0.86(0.54%)
Day’s Range― - ―
52-Week Range$115.35 - $307.06
Previous CloseN/A
Volume21.34K
Average Volume (3M)317.41K
Market Cap
$6.71B
Enterprise Value$5.63K
Total Cash (Recent Filing)$303.13M
Total Debt (Recent Filing)$267.67M
Price to Earnings (P/E)36.2
Beta1.05
Next Earnings
Jul 29, 2026EPS Estimate
2.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.98
Shares Outstanding26,756,420
10 Day Avg. Volume281,570
30 Day Avg. Volume317,411
Financial Highlights & Ratios
PEG Ratio0.40
Price to Book (P/B)2.66
Price to Sales (P/S)0.96
P/FCF Ratio25.16
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$300.00Price Target Upside31.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)8.2
Revenue Forecast (FY)$4.72B
Bulls Say, Bears Say
Bulls Say
Record Program Wins And Expanding FunnelSizable quarterly wins and a $4B qualified funnel provide multi‑year revenue visibility across aerospace, industrial and healthcare. A deep, growing pipeline supports sustained new product introductions and recurring program life cycles, underpinning durable top‑line expansion.
Conservative Balance Sheet And Improving ReturnsLow leverage and rising equity give financial flexibility for capex, buybacks or opportunistic M&A without stressing liquidity. Improving ROE signals better capital efficiency, making the company more resilient to industry cycles and able to fund growth initiatives over multiple years.
Expanded Credit Facility Increases Strategic OptionalityA long‑dated, expandable revolver secures liquidity for capacity investments, working capital swings and bolt‑on M&A. The facility reduces refinancing risk, supports multi‑year growth plans and enables management to pursue strategic investments without immediate balance sheet strain.
Bears Say
Weakened Free Cash Flow ConversionRecent declines in free cash flow conversion reduce financial flexibility for investments and shareholder returns. If FCF remains depressed amid higher working capital and capex plans, the company may need to rely more on credit or temper buybacks, affecting long‑term capital allocation.
Thin Margins And Sensitivity To Ramp/investment CostsRelatively low margins mean profitability is highly sensitive to mix, ramp inefficiencies and commodity cost moves. Investment and ramp expenses can compress operating margins for multiple quarters, requiring sustained scale or pricing power to restore durable margin expansion.
Supply Chain Tightness And Long Ramp TimelinesExtended lead times and allocation risk can delay program ramps, pushing revenue recognition and increasing inventory/working capital needs. Long, variable ramp cycles raise execution risk and can postpone the cash‑flow and margin benefits from recent contract wins over the next several quarters.
Plexus News
PLXS FAQ
What was Plexus’s price range in the past 12 months?
Plexus lowest stock price was $115.35 and its highest was $307.06 in the past 12 months.
What is Plexus’s market cap?
Plexus’s market cap is $6.71B.
When is Plexus’s upcoming earnings report date?
Plexus’s upcoming earnings report date is Jul 29, 2026 which is in 8 days.
How were Plexus’s earnings last quarter?
Plexus released its earnings results on Apr 29, 2026. The company reported $2.05 earnings per share for the quarter, beating the consensus estimate of $1.883 by $0.167.
Is Plexus overvalued?
According to Wall Street analysts Plexus’s price is currently Undervalued.
Does Plexus pay dividends?
Plexus does not currently pay dividends.
What is Plexus’s EPS estimate?
Plexus’s EPS estimate is 2.13.
How many shares outstanding does Plexus have?
Plexus has 26,756,420 shares outstanding.
What happened to Plexus’s price movement after its last earnings report?
Plexus reported an EPS of $2.05 in its last earnings report, beating expectations of $1.883. Following the earnings report the stock price went down -0.008%.
Which hedge fund is a major shareholder of Plexus?
Currently, no hedge funds are holding shares in PLXS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Plexus Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$300.00 (31.21% Upside)
$300.00 (31.21% Upside)
Blogger Sentiment
Neutral
PLXS Sentiment 50%
Sector Average 64%
Sector Average 64%
Hedge Fund Trend
Increased
By 23.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 5.0%
Last 30 Days ▲ 5.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
80.49%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8.92%
Trailing 12-Months
Company Description
Plexus
Operating globally across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions, Plexus Corp. and its subsidiaries specialize in delivering advanced electronic manufacturing solutions. The company provides a comprehensive range of services, including design and development, efficient supply chain management, support for new product introductions, and core manufacturing capabilities, alongside essential aftermarket services. These offerings are tailored for businesses in key market segments such as healthcare/life sciences, industrial/commercial, aerospace/defense, and communications. Established in 1979, Plexus Corp. maintains its corporate headquarters in Neenah, Wisconsin.
PLXS Stock 12 Month Forecast
Average Price Target
$300.00
▲(31.21% Upside)
Technical Analysis
Ownership Overview
1.41% Insiders
31.70% Mutual Funds
0.60% Other Institutional Investors
34.71% Public Companies and
Individual Investors